Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus - Are there any associations?

Tissue Antigens

Volumn 62, Issue 5, 2003, Pages 394-400

  Roxo, V M M S ^a   Pereira, N F ^a   Pavoni, D P ^b   Lin, M T ^c   Hansen, J A ^c   Poersch, C D O ^a,b   Marquart Filho, A ^d   Petzl Erler, M L ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Instituto de Biologia Molecular do Parana   (Brazil)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Hospital Adventista do Penfigo   (Brazil)

Author keywords

Fogo selvagem; Lymphotoxin alpha; Pemphigus foliaceus; Polymorphism; Tumor necrosis factor

Indexed keywords

DESMOGLEIN 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G4; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ACANTHOLYSIS; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENDEMIC DISEASE; EPIDERMIS CELL; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; GENE FREQUENCY; HAPLOTYPES; HETEROZYGOTE; HUMANS; LYMPHOTOXIN-ALPHA; PEMPHIGUS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

PEMPHIGUS;

EID: 0242364724     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00115.x     Document Type: Article

References (43)

1. Beutner EM, Jordon RE. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol Med 1964: 117: 505-10.
2. Koulu L, Kusumi L, Steinberg MS, Klaus-Kovtun V, Stanley JR. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 1984: 160: 1509-18.
3. Rock B, Martins CR, Theofilopoulos NA et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989: 320: 1463-9.
4. Diaz LA, Sampaio SAP, Rivitti EA et al. Endemic pemphigus foliaceus (fogo selvagem). II. Current and historic epidemiologic studies. J Invest Dermatol 1989: 92: 4-12.
5. Sevadjian C. Nosology of Brazilian Pemphigus Foliaceus. Int J Dermatol 1979: 18: 781-86.
6. Lombardi C, Borges PC, Chaul A et al. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol 1992: 98: 847-50.
7. Petzl-Erler ML, Santamaria J. Are HLA class II genes controlling susceptibility and resistance to Brazilian pemphigus foliaceus (fogo selvagem)? Tissue Antigens 1989: 33: 408-14.
8. Moraes ME, Fernandez-Viña M, Lazaro L et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997: 49: 35-40.
9. Pavoni DP, Roxo VMMS, Marquart AF, Petzl-Erler ML. Dissecting the associations of endemic pemphigus foliaceus (fogo selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun 2003: 4: 110-6.
10. Smyth MJ, Johnstone RW. Role of TNF lymphocyte-mediated cytotoxicity. Microsc Res Tech 2000: 50: 196-208.
11. Aggarwal B, Eessalu TE, Hass PE. Characterization of receptors for human necrosis factor and their regulation by gamma-interferon. Nature 1985: 318: 665-7.
12. Kehrl JH, Alvarez-Mon M, Delsing GA, Fauci AS. Lymphotoxin is an important T-cell derived growth factor for human B cells. Science 1987: 238: 1144-6.
13. Guo W, Mourad W, Charron D, Al-Daccak R. Ligation of MHC class II molecules differentially upregulates TNFα gene expression in B cell lines of different MHC class II haplotypes. Hum Immunol 1999: 60: 312-22.
14. Goldfeld AE, Doyle C, Maniatis T. Exp Parasit 1996: 84: 300-3.
15. Ma X. TNF-α and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001: 3: 121-9.
16. López-Robles E, Avalos-Diaz E, Vega-Memije E et al. TNF alpha and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol 2001: 3: 185-8.
17. Wilson AG, Symons JA, McDowell TL, di Giovine F, Duff GW. Effects of a tumor necrosis factor (TNF alpha) promoter base transition on transcriptional activity. Br J Rheumatol 1994: 33: 89-92.
18. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leuk Biol 1999: 66: 562-6.
19. Messer G, Spengler H, Jung MC et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino-acid in position 26 and a reduced level of the TNF-β production. J Med 1991: 173: 209-19.
20. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999: 1: 3-19.
21. Lahiri DK, Nurberger JR. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res 1991: 19: 5444.
22. Verjans GM, Brinkman BMN, van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-alpha (TNF-α) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994: 97: 45-7.
23. Fanning GC, Bunce C, Black CM, Welsh KI. Polymerase chain reaction haplotyping using-3′mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α. Tissue Antigens 1997: 50: 23-31.
24. Tseng LH, Chen PJ, Lin MT et al. Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, Il-10, TNFα and TNFα genes. Tissue Antigens 2002: 59: 280-6.
25. Schneider RF, Roessly D, Excofier L. ARLEQUIN: a software for population genetic data analysis, version 2.000. Geneva: Genetics and Biometry Laboratories, Department of Anthropology, University of Geneva, 2000.
26. Miller MP. RxC: a program for the analyses of contingency tables via the Metropolis Algorithm. Computer software distributed by the author, 1997.
27. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-11.
28. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in a tumor necrosis factor gene associated with mucocutaneous leishmaniasis. J Exp Med 1995: 182: 1259-64.
29. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumour necrosis factor-alpha promoter region may be associated with death from meningococcal disease. J Infect Dis 1996: 174: 878-80.
30. Danis VA, Millington M, Hyland V et al. Increased frequency of the uncommon allele of tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1995: 12: 127-33.
31. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000: 3: 129.
32. Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001: 2: 363-6.
33. Manus RM, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis factor-alpha gene promoter, is a component of the coeliac disease major histocompatibility complex haplotype. Eur J Immunol 1996: 26: 2113-8.
34. Kula D, Jurecka-Tuleja B, Gubala E, Krawczyk A, Szpak S, Jarzab M. Associations of polymorphism of Lt alpha and TNF genes with Graves' disease. Folia Histochem Cytobiol 2001: 39: 77-8.
35. Brinkman BMN, Zuijdesst D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene expression. J Inflamm 1996: 46: 32-41.
36. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibilty complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993: 23: 224-31.
37. Cuenca J, Pérez C, Aguirre A, Schiattino I, Aguillón JC. Genetic polymorphism at position .308 in the promoter of the tumor necrosis factor (TNF): Implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res 2001: 34: 237-41.
38. Conway DJ, Holland MJ, Bailey RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-a levels in tear fluid. Infect Immunol 1997: 65: 1003-6.
39. Brinkman BM, Huizinga TW, Kurban SS et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997: 36: 516-21.
40. Higuchi T, Seki N, Kamizono S et al Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF) -α gene in Japanese. Tissue Antigens 1998: 51: 605-12.
41. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999: 8: 1443-9.
42. Pantelidis P, Fanning GC, Wells AU, Welsh KI. Analysis of tumour necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001: 163: 1432-6.
43. Hampe J, Shaw SH, Saiz R et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999: 65: 1647-55.